Pricing Log in Create free account

BioVie Inc. (BIVI) vs VistaGen Therapeutics, Inc. (VTGN)

BioVie Inc. and VistaGen Therapeutics, Inc. are both Biotechnology companies. BioVie Inc. and VistaGen Therapeutics, Inc. are of similar size ($9.6M and $9.5M). BioVie Inc. has the higher net margin (0.00% vs −2,703.7%) and the lower return on invested capital (−1,095.0% vs 0.00%). Across the 13 metrics below, BioVie Inc. leads on 10 and VistaGen Therapeutics, Inc. on 3.

Valuation

Metric BIVI VTGN Biotechnology median
P/E n/m n/m 8.50
P/S n/m 3.44 9.71
P/B 0.85 0.35 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.21 0.64
EV/Sales n/m (5.93) 9.21
Earnings yield (262.50%) (830.00%) (33.15%)
Free cash flow yield (218.80%) (726.47%) (25.50%)

Profitability

Metric BIVI VTGN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (2,785.69%) 0.00%
Net margin 0.00% (2,703.72%) 0.00%
Free cash flow margin 0.00% (2,490.88%) 0.00%
Return on equity (151.06%) (166.46%) (56.36%)
Return on assets (123.51%) (129.22%) (48.04%)
Return on invested capital (1,095.01%) 0.00% 0.00%

Growth

Metric BIVI VTGN Biotechnology median
Revenue growth (TTM) — 287.15% 6.02%
EPS growth (last fiscal year) 74.83% (9.58%) 30.26%
Revenue growth, 5-year CAGR — 3.10% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIVI VTGN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.59 3.07 4.72
Net debt to EBITDA 0.40 0.63 0.96

Dividend

Metric BIVI VTGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BIVI VTGN Biotechnology median
Market cap 9.64m 9.45m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack